Archivos de Bronconeumología

ISSN: 0300-2896

Archivos de Bronconeumologia is a scientific journal that preferentially publishes prospective original research articles whose content is based upon results dealing with several aspects of respiratory diseases such as epidemiology, pathophysiology, clinics, surgery, and basic investigation. Other types of articles such as reviews, editorials, a few special articles of interest to the society and the editorial board, scientific letters, letters to the Editor, and clinical images are also published in the Journal. It is a monthly Journal that publishes a total of 12 issues and a few supplements, which contain articles belonging to the different sections.

All the manuscripts received in the Journal are evaluated by the Editors and sent to expert peer-review while handled by the Editor and/or an Associate Editor from the team. The Journal is published monthly in English.

Manuscripts will be submitted electronically using the following web site: https://www.editorialmanager.com/ARBR/, link which is also accessible through the main web page of Archivos de Bronconeumologia.

Access to any published article, is possible through the Journal's web page as well as from PubMed, Science Direct, and other international databases. Furthermore, the Journal is also present in Twitter and Facebook. The Journal expresses the voice of the Spanish Respiratory Society of Pulmonology and Thoracic Surgery (SEPAR) as well as that of other scientific societies such as the Latin American Thoracic Society (ALAT) and the Iberian American Association of Thoracic Surgery (AICT).

Authors are also welcome to submit their articles to the Journal's open access companion title, Open Respiratory Archives.

Archivos de Bronconeumologia has received the new Impact Factor (JCR). The impact factor has risen from 6.333 in 2021 to 8 in the last evaluated year, 2022.
It is needed to be a member of SEPAR or have a subscription to access full texts of articles published last year. Abstracts are available for all visitors.

Indexed in:

Current Contents/Clinical Medicine, JCR SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, SCOPUS, IBECS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2022

Citescore

CiteScore measures average citations received per document published.

Citescore 2022

2.8

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2022

0.434

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2022

0.437

View more metrics

Open Access Option

Journal Information

Previous article | Next article

Vol. 50. Issue 9.

Pages 373-374 (September 2014)

Export reference

Download PDF

Statistics

Follow this link to access the full text of the article

Editorial

Will We Be Treating Tuberculosis With Vaccines in the xxi Century?

¿Trataremos la tuberculosis con vacunas en el siglo xxi?

Juan Ruiz Manzanoa,

Corresponding author

jruiz@separ.es

Corresponding author.

, Cristina Vilaplanab

a Servicio de Neumología, Hospital Universitario Germans Trias y Pujol, Badalona, Departamento de Medicina de la Universidad Autónoma de Barcelona (UAB), CIBER de respiratorio (CIBERes), Spain

b Unitat de Tuberculosi Experimental, Fundació Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain

Read

3515

Times
was read the article

1447

Total PDF

2068

Total HTML

Share statistics

Article information

ISSN: 15792129
Original language: English

DOI:10.1016/j.arbr.2014.06.018

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 April	17	23	40
2024 March	22	18	40
2024 February	22	21	43
2023 March	5	0	5
2023 February	19	20	39
2023 January	17	22	39
2022 December	37	26	63
2022 November	30	23	53
2022 October	31	29	60
2022 September	17	20	37
2022 August	25	29	54
2022 July	21	37	58
2022 June	17	41	58
2022 May	19	34	53
2022 April	25	24	49
2022 March	24	31	55
2022 February	24	25	49
2022 January	17	31	48
2021 December	21	36	57
2021 November	22	36	58
2021 October	24	34	58
2021 September	33	48	81
2021 August	10	22	32
2021 July	22	23	45
2021 June	27	38	65
2021 May	41	28	69
2021 April	87	47	134
2021 March	48	28	76
2021 February	19	14	33
2021 January	13	13	26
2020 December	10	19	29
2020 November	11	8	19
2020 October	15	2	17
2020 September	9	9	18
2020 August	18	12	30
2020 July	18	16	34
2020 June	15	8	23
2020 May	14	11	25
2020 April	22	18	40
2020 March	12	10	22
2020 February	17	15	32
2020 January	19	19	38
2019 December	14	16	30
2019 November	17	10	27
2019 October	9	6	15
2019 September	4	4	8
2019 August	17	12	29
2019 July	31	19	50
2019 June	14	12	26
2019 May	8	12	20
2019 April	17	31	48
2019 March	16	18	34
2019 February	19	13	32
2019 January	10	7	17
2018 December	16	16	32
2018 November	28	15	43
2018 October	49	27	76
2018 September	24	10	34
2018 May	6	0	6
2018 April	16	8	24
2018 March	17	1	18
2018 February	14	5	19
2018 January	14	7	21
2017 December	17	4	21
2017 November	15	3	18
2017 October	19	13	32
2017 September	23	8	31
2017 August	29	7	36
2017 July	27	10	37
2017 June	33	11	44
2017 May	29	6	35
2017 April	23	6	29
2017 March	28	22	50
2017 February	13	2	15
2017 January	14	6	20
2016 December	27	6	33
2016 November	19	5	24
2016 October	28	17	45
2016 September	24	12	36
2016 August	30	8	38
2016 July	19	6	25
2016 May	1	0	1
2016 March	1	0	1
2015 December	2	0	2
2015 October	34	1	35
2015 September	30	6	36
2015 August	35	11	46
2015 July	36	4	40
2015 June	30	4	34
2015 May	54	16	70
2015 April	30	5	35
2015 March	31	6	37
2015 February	20	4	24
2015 January	24	7	31
2014 December	26	11	37
2014 October	0	3	3
2014 September	1	0	1

Show all

Follow this link to access the full text of the article

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter